BiomX Obtains Option to Acquire Control of Israeli Laser-Radar Counter-Drone System
Rhea-AI Summary
BiomX (NYSE American: PHGE) entered an option agreement to acquire control of DFSL, a developer of LADAR (laser radar) detection systems, with the transaction estimated at approximately $45 million if closed. Consideration may include cash, a convertible promissory note, common shares and warrants exercisable at $12 per share. BiomX plans to pivot into security, defense and first-response markets; the deal is subject to Israeli regulatory approval and customary closing and shareholder approvals. DFSL’s platform claims ~99% real-world detection accuracy and is deployed in transportation and defense settings.
Positive
- Estimated transaction value of approximately $45 million
- Demonstrated detection accuracy of ~99% in real-world deployments
- Entry into defense/security markets with existing deployments in transport and military settings
- Third-party credit line committed to facilitate operations and geographic expansion
Negative
- Transaction subject to Israeli regulatory and shareholder approval
- Consideration includes convertible note and warrants, creating potential future dilution
- Strategic pivot from core business into defense/security increases execution and integration risk
News Market Reaction – PHGE
In the Mar 31 session, PHGE declined 16.39%, reflecting a significant negative market reaction. Argus tracked a peak move of +20.0% during that session. Argus tracked a trough of -31.5% from its starting point during tracking. Our momentum scanner triggered 19 alerts that day, indicating notable trading interest and price volatility. Trading volume was elevated at 2.6x the daily average, suggesting increased selling activity.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
Historical Context
| Date | Event | Sentiment | 24h Move | Catalyst |
|---|---|---|---|---|
| Mar 30 | Advisory board addition | Positive | -2.8% | Appointed ex-Mossad deputy to guide expansion into security and defense. |
| Mar 26 | Security unit launch | Positive | -3.7% | Launched Israeli security subsidiary and committed over $3M internal funding. |
| Mar 19 | Strategic reset letter | Positive | -1.2% | CEO outlined financial reset, warrant amendments, cost cuts, defense pivot. |
| Mar 09 | New CEO & CFO | Positive | +9.0% | Named new CEO and CFO with M&A and capital markets experience. |
| Jan 27 | Trading activity statement | Neutral | +69.5% | Company said it knew of no undisclosed developments behind unusual trading. |
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Recent positive strategic and governance updates often coincided with negative or muted price reactions, except for one CEO/CFO appointment that drew a strong gain. A prior trading-activity statement preceded a sharp rise without new fundamentals, suggesting history of price moves that sometimes diverge from news tone.
Over the past months, BiomX has undergone significant strategic and leadership change. On March 4, 2026, a new CEO and later a new CFO were installed to drive a reset toward advanced technologies and defense-related applications. Subsequent communications, including a CEO letter on March 19, 2026 and launches of security-focused initiatives, highlighted a pivot into security, defense, and first-response markets. Advisory board additions with deep intelligence backgrounds further supported this shift. Today’s counter-drone LADAR option agreement continues that transition away from prior solely biotech positioning.
Key Terms
ladar technical
lidar technical
uav technical
counter-uas technical
warrants financial
convertible note financial
form 8-k regulatory
ai algorithm technical
AI-generated analysis. How Rhea-AI works. Not financial advice.
The platform delivers ~
NETANYA, Israel, March 31, 2026 (GLOBE NEWSWIRE) -- BiomX Inc. (NYSE American: PHGE) today announced that it has entered into an option agreement to acquire control of DFSL, a developer of proprietary LADAR (Laser Radar)–based detection systems for security, defense, and critical infrastructure applications. DFSL’s LADAR technology combines laser-based sensing with proprietary AI algorithms to detect and respond to both UAV and ground-based intruders.
BiomX intends to exercise the option subject to the closing of the underlying agreement and obtaining shareholder approval as necessary or consideration consisting of a combination of cash, promissory note, shares of common stock and warrants. Separately, a third party has agreed to provide a credit line to facilitate operations and company expansion across different geographies.
The transaction marks BiomX’s pivot into security, defense, and first-response markets. These sectors are supported by growing demand and government investment, with the global counter-drone market expected to reach more than
False positives remain a persistent challenge in modern security systems. Environmental factors such as wind, rain, or movement can trigger unnecessary alerts, leading to “alarm fatigue” and reduced operator effectiveness. In high-noise environments, these false alarms can overwhelm operators, undermining system reliability and slowing response times. Conventional LiDAR systems, which rely on external data processing, often struggle to filter this noise in real-world conditions.
DFSL’s LADAR platform addresses this challenge by combining laser-based sensing with a proprietary AI algorithm that processes data within the sensor itself. This enables the system to analyze what it detects in real time, identify and track targets while distinguishing real threats from background activity rather than simply detecting motion. As a result, the platform significantly reduces false alarms while maintaining high detection certainty, with demonstrated accuracy of approximately
Founded in 1995 by Dr. Yaacov Frucht, a former senior research leader at Rafael Advanced Defense Systems, DFSL builds on defense-originated laser radar technology adapted for civilian and homeland security use.
DFSL’s technology is deployed across four primary application areas: counter-UAS (drone detection and response), perimeter and border security (“virtual fencing”), wide-area 360-degree surveillance, and rail and metro safety systems. The platform has been deployed in both pilot and operational environments where reliable, low false-alarm detection is critical, including transportation infrastructure and defense-related settings. Through integration partners, DFSL systems have been deployed in military operations in Israel and Africa, as well as in major transportation systems, including the Los Angeles Metro.
The technology has been supported by government development programs including the Israel Innovation Authority and European security initiatives, and is protected by a portfolio of patents covering both hardware design and signal processing methodologies. DFSL has also participated in multiple European Union–funded security programs focused on border protection and critical infrastructure, where its LADAR technology serves as a core detection layer within integrated systems designed to identify and respond to both ground and aerial threats in complex, real-world environments.
“This transaction represents our entry point into the defense and security sector, where we see strong and growing demand driven by evolving global threats and increasing infrastructure protection needs,” said Michael Oster, CEO of BiomX. “DFSL brings a proven technology platform with real-world deployments, positioning us to establish an initial presence in high-demand markets such as counter-UAS and perimeter security. From this starting point, we plan to expand capabilities, increase deployment across new geographies, and build a broader footprint in defense and critical infrastructure markets over time.”
The transaction is subject to regulatory approval in Israel and customary closing conditions. Consideration includes a convertible note and warrants, in each case convertible or exercisable at
Forward-Looking Statements
This press release contains “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, including statements regarding the expected benefits of the transaction, anticipated market opportunities, and potential performance of DFSL’s technology. These statements are based on current expectations and involve risks and uncertainties that could cause actual results to differ materially.
Factors that may affect future results include, among others, the Company’s ability to complete the transaction, integrate DFSL, commercialize its technology, and execute its strategy in defense and infrastructure markets. Additional information regarding these risks is included in BiomX’s filings with the U.S. Securities and Exchange Commission.
BiomX undertakes no obligation to update any forward-looking statements, except as required by law.
For more information, please contact: Yair Ohayon Yairo@biomx.com